RLMD insider transaction filings
RELMADA THERAPEUTICS, INC. — 23 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-12-16. Screen RLMD transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-12-16 | 4 | TRAVERSA SERGIO — Chief Executive Officer, Director | Purchase (P): 27,500 @ $4.12 · Grant/award (A): 1,198,000 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | Shenouda Maged — Chief Financial Officer | Purchase (P): 11,665 @ $4.12 · Grant/award (A): 828,000 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | Ence Chuck — CA and CO | Grant/award (A): 828,000 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | Fedeli Fabiana — Director | Grant/award (A): 164,000 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | GLASSPOOL JOHN — Director | Grant/award (A): 164,000 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | Kelly Paul Edward — COO, Director | Grant/award (A): 828,000 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | CASAMENTO CHARLES J — Director | Grant/award (A): 164,000 (derivative) @ $0 | EDGAR |
| 2025-11-06 | 4 | Ence Chuck — CAO and COO | Purchase (P): 136,000 @ $2.20 | EDGAR |
| 2025-11-06 | 4 | TRAVERSA SERGIO — Chief Executive Officer, Director | Purchase (P): 272,500 @ $2.20 | EDGAR |
| 2025-11-06 | 4 | Shenouda Maged — Chief Financial Officer | Purchase (P): 500,000 @ $2.20 | EDGAR |
| 2025-11-06 | 4 | Kelly Paul Edward — Chief Operating Officer, Director | Purchase (P): 90,000 @ $2.20 | EDGAR |
| 2025-08-28 | 4 | TRAVERSA SERGIO — Chief Executive Officer, Director | Purchase (P): 80,545 @ $0.62 · Purchase (P): 129,455 @ $0.67 · Purchase (P): 55,976 @ $0.74 | EDGAR |
| 2025-06-30 | 4 | Ence Chuck — CA and CO | Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4 | Shenouda Maged — Chief Financial Officer | Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4 | TRAVERSA SERGIO — Chief Executive Officer, Director | Grant/award (A): 800,000 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4 | GLASSPOOL JOHN — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4 | Fedeli Fabiana — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4 | Kelly Paul Edward — Chief Operating Officer, Director | Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4 | CASAMENTO CHARLES J — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-05-20 | 4 | Kelly Paul Edward — Chief Operating Officer, Director | Purchase (P): 200,000 @ $0.43 | EDGAR |
| 2025-05-20 | 4 | Shenouda Maged — Chief Financial Officer | Purchase (P): 50,000 @ $0.44 · Purchase (P): 90,000 @ $0.49 · Purchase (P): 60,000 @ $0.52 | EDGAR |
| 2025-05-20 | 4 | Ence Chuck — CA and CO | Purchase (P): 228,961 @ $0.45 | EDGAR |
| 2025-05-20 | 4 | TRAVERSA SERGIO — Chief Executive Officer, Director | Purchase (P): 172,314 @ $0.45 · Purchase (P): 30,000 @ $0.50 · Purchase (P): 147,686 @ $0.56 | EDGAR |
Recent 8-K events — RELMADA THERAPEUTICS, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-28 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-28 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-12 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-20 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-09 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-15 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-13 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-05 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-04 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=RLMD returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →